Startup · $35.3m raised
Sydney, NSW
Every investor coverage indicates participated in a round HealthMatch raised.
| Investor | Rounds | Invested |
|---|---|---|
| Anton Borzov | Series A | - |
| Brandon Carp | Series B | - |
| Catherine Lacavera | Series A | - |
| Folklore Ventures | Series C | - |
| January Capital | Series B | - |
| Lucy Turnbull | Series B | - |
| Malcolm Turnbull | Series B | - |
| Nicky Carp | Series B | - |
| Paul Bassat | Series A | - |
| Square Peg Capital | Series C · Series B · Series A | - |
| Stephen Fitzgerald | Series A | - |
| Tempus Partners | Series B · Series A · Seed | - |
| the family office of Malcolm Turnbull and Lucy Turnbull | Series B | - |
Investors whose own portfolio pages list HealthMatch, even though we haven't found any coverage of the round yet.
| Investor | Listed on |
|---|---|
| Athletic Ventures | its portfolio page ↗ |
Companies HealthMatch acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming HealthMatch. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
A student-run venture fund launches alongside research showing university founders have attracted backing topping $1.2 billion, though women-led teams receive a small share; Blackbird is the most active backer.
Techboard's September 2022 roundup reports Australian raises led by Morse Micro's $140m Series B, several acquisitions including ResApp Health to Pfizer, fund closes by Telstra Ventures, OIF and Main Sequence, and open raises.
A weekly roundup covering five funding rounds: HealthMatch's Series C, Monday Distillery's crowdfunding, Sonder's Series B, Lleaf's bridge round, and Spice AI's seed raise.
Sydney clinical trials platform HealthMatch raised a $10 million Series C led by Folklore Ventures with Square Peg participating, after laying off half its staff in June; funds will support rehiring and US expansion.
Also SmartCompany·Techboard
Square Peg's retrospective of 2019: five new portfolio companies, several large rounds it led or co-led, two acquisitions, two IPOs, new team members, and its capital deployed across new and follow-on deals.
Also TechCrunch Venture·SmartCompany·Startup Daily·Square Peg Capital portfolio·Startup Daily·Startup Daily·Startup Daily·SmartCompany·Startup Daily·Startup Daily·SmartCompany·Startup Daily·Startup Daily·SmartCompany·Startup Daily·SmartCompany·Startup Daily·SmartCompany·SmartCompany·SmartCompany·Startup Daily·Startup Daily·Startup Daily·Startup Daily·SmartCompany·SmartCompany·Startup Daily·@AuManufacturing·StrictlyVC·Startup News (WA)·Australian FinTech·Australian FinTech·@AuManufacturing·TechCrunch Venture·TechCrunch Venture·Crunchbase News
Square Peg's investment note explains why it backed e-scooter operator Neuron's US$18.5 million Series A with GSR Ventures, highlighting the company's city-permit strategy across Australia and New Zealand.
Square Peg's investment note recounts co-leading HealthMatch's $6 million Series A after an accelerated five-day process, profiling founder Manuri Gunawardena's clinical trial matching platform and existing backer Tempus Partners.
Also Square Peg Capital portfolio·Startup Daily·SmartCompany·Startup Daily·Startup Daily·SmartCompany·Startup Daily·SmartCompany·Startup Daily·Startup Daily·SmartCompany·Women's Agenda
Profile of HealthMatch founder and chief executive Manuri Gunawardena, covering the patient-trial matching platform's investor backing and her win at Veuve Clicquot's Bold Future Award.
Square Peg Capital recaps 2020: eight new investments including Zeller and HealthMatch, a US$450 million fourth fund close, follow-ons, new hires across Sydney, Singapore and Israel, and portfolio updates.
Also Square Peg Capital portfolio·Square Peg Capital portfolio·SmartCompany·Australian FinTech·Startup Daily·SmartCompany·SmartCompany·SmartCompany·Startup Daily·SmartCompany·SmartCompany·SmartCompany·Startup Daily·SmartCompany·Startup Daily·SmartCompany·Startup Daily·SmartCompany·Startup Daily·Startup Daily·Startup Daily·SmartCompany·Startup Daily·Women's Agenda·Australian FinTech·Crunchbase News·TechCrunch Venture
A roundup profiling ten Australian startups expected to grow in 2021, reporting raises by VAPAR, HealthMatch, Ovira, Heaps Normal, Vop and Outland Denim, plus grants, accelerator alumni and founders' plans.
Square Peg has closed a $600 million fourth fund, capping a year in which Australian venture funds collectively gathered over $1.6 billion, with closes by Blackbird, OneVentures, Equity Venture Partners, Antler, Tidal and others.
Square Peg led HealthMatch's $18 million round, with the Turnbilns, the Carps and January Capital joining; Tempus Partners returned. Square Peg earlier led HealthMatch's $6 million series A, and UHG was acquired by Medhealth.
Clinical trials matching startup HealthMatch, founded by a UNSW medical student, has closed a $6 million Series A led by Square Peg Capital and Tempus Partners, with Paul Bassat joining its board and a Roche partnership announced.
Also SmartCompany
Folklore Ventures founder story recalling its seed backing of Manuri Gunawardena's clinical trial matching startup HealthMatch, plus follow-ons in its Series A and December 2020 Series B alongside Square Peg.